Adolescent social isolation increases anxiety-like behavior and ethanol intake and impairs fear extinction in adulthood: Possible role of disrupted noradrenergic signaling
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Alcohol use disorder, anxiety disorders, and post-traumatic stress disorder (PTSD) are highly comorbid, and exposure to chronic stress during adolescence may increase the incidence of these conditions in adulthood. Efforts to identify the common stress-related mechanisms driving these disorders have been hampered, in part, by a lack of reliable preclinical models that replicate their comorbid symptomatology. Prior work by us, and others, has shown that adolescent social isolation increases anxiety-like behaviors and voluntary ethanol consumption in adult male Long-Evans rats. Here we examined whether social isolation also produces deficiencies in extinction of conditioned fear, a hallmark symptom of PTSD. Additionally, as disrupted noradrenergic signaling may contribute to alcoholism, we examined the effect of anxiolytic medications that target noradrenergic signaling on ethanol intake following adolescent social isolation. Our results confirm and extend previous findings that adolescent social isolation increases anxiety-like behavior and enhances ethanol intake and preference in adulthood. Additionally, social isolation is associated with a significant deficit in the extinction of conditioned fear and a marked increase in the ability of noradrenergic therapeutics to decrease ethanol intake. These results suggest that adolescent social isolation not only leads to persistent increases in anxiety-like behaviors and ethanol consumption, but also disrupts fear extinction, and as such may be a useful preclinical model of stress-related psychopathology. Our data also suggest that disrupted noradrenergic signaling may contribute to escalated ethanol drinking following social isolation, thus further highlighting the potential utility of noradrenergic therapeutics in treating the deleterious behavioral sequelae associated with early life stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heim, C., & Nemeroff, C. B. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01157-x · Cited by 2,791
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529 · cited 2×
“…throughout the neuraxis, targeting many regions involved in generating and terminating appropriate behavioral and neuroendocrine responses to stressors (Berridge and Waterhouse, 2003); as such, noradrenergic pharmacotherapeutics likely exert their effects by acting on a number of LC targets.”
BackgroundPlasticity of reward neurocircuitry and the ‘dark side’ of drug addiction
Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963 · cited 1×
“113 114 115 116 ., et al., Adolescent social isol e of disrupted noradrenerg contrast, alcohol withdrawal enhances anxiety and exacerbates PTSD symptomatology, thereby promoting further intake (Becker, 2012; Driessen et al., 2001; Koob and Le Moal, 2005; Robinson et al., 2011).”
BackgroundBruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., Shea, M. T., & Keller, M. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1179 · Cited by 963 · cited 2×
“, 2011; Koob, 2013), and individuals suffering from comorbid PTSD, alcohol use disorder, and anxiety disorders exhibit worsened clinical profiles and experience poorer treatment outcomes (Bruce et al., 2005; Jacobsen et al., 2001).”
BackgroundThe role of early life stress as a predictor for alcohol and drug dependence
Enoch, M.-A. (2011) · Psychopharmacology · doi:10.1007/s00213-010-1916-6 · Cited by 668 · cited 4×
“…121 122 123 124 125 126 127 128 129 130 together, our findings to date support extant evidence that chronic stress in adolescence may increase behaviors reminiscent of alcohol use and anxiety disorders in later life (Brady and Sinha, 2005; Enoch, 2011; Gillespie et al., 2009; Kaufman et al., 2007).”
BackgroundInfluentialRole of brain norepinephrine in the behavioral response to stress
Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & Petre, C. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.007 · Cited by 570
Presence and acquired origin of reduced recall for fear extinction in PTSD: Results of a twin study
Milad, M. R., Orr, S. P., Lasko, N. B., Chang, Y., Rauch, S. L., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.01.017 · Cited by 512
CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder
Geracioti, T. D., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1227 · Cited by 462
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462
Models and mechanisms of anxiety: evidence from startle studies
Grillon, C. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1019-1 · Cited by 456 · cited 2×
“…herein extend previous studies by using the fear-potentiated startle paradigm, a highly translational and clinically relevant measure of fear learning (Grillon, 2008; Jovanovic et al., 2013), to examine whether adolescent isolation also produces disruptions in fear and extinction learning.”
ResultImpaired fear inhibition is a biomarker of PTSD but not depression
Jovanovic, T., Norrholm, S. D., Blanding, N. Q., Davis, M., Duncan, E., Bradley, B., & Ressler, K. J. (2010) · Depression and Anxiety · doi:10.1002/da.20663 · Cited by 444 · cited 19×
“Taken together, these findings point to noradrenergic dysregulation as a potential common mechanism driving the development and maintenance of stress-related anxiety, PTSD, and alcohol use disorder.”
BackgroundInfluentialDahl, R. E., & Gunnar, M. R. (2009) · Development and Psychopathology · doi:10.1017/s0954579409000017 · Cited by 409
Risk and resilience: genetic and environmental influences on development of the stress response
Gillespie, C. F., Phifer, J., Bradley, B., & Ressler, K. J. (2009) · Depression and Anxiety · doi:10.1002/da.20605 · Cited by 351 · cited 4×
“…121 122 123 124 125 126 127 128 129 130 together, our findings to date support extant evidence that chronic stress in adolescence may increase behaviors reminiscent of alcohol use and anxiety disorders in later life (Brady and Sinha, 2005; Enoch, 2011; Gillespie et al., 2009; Kaufman et al., 2007).”
BackgroundInfluentialGrillon, C., & Morgan, C. A. (1999) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.108.1.134 · Cited by 331
Romeo, R. D., Bellani, R., Karatsoreos, I. N., Chhua, N., Vernov, M., Conrad, C. D., & McEwen, B. S. (2006) · Endocrinology · doi:10.1210/en.2005-1432 · Cited by 304 · cited 1×
“This disparity is consistent with the hypothesis that protracted activation of the stress response system during adolescence leads to long-lasting neurobiological and behavioral perturbations (Heim and Nemeroff, 2001; Romeo et al., 2006; Spear, 2009).”
ResultLeeies, M., Pagura, J., Sareen, J., & Bolton, J. M. (2010) · Depression and Anxiety · doi:10.1002/da.20677 · Cited by 300 · cited 17×
“Taken together, these findings point to noradrenergic dysregulation as a potential common mechanism driving the development and maintenance of stress-related anxiety, PTSD, and alcohol use disorder.”
BackgroundInfluentialChronic alcohol remodels prefrontal neurons and disrupts NMDAR-mediated fear extinction encoding
Holmes, A., Fitzgerald, P. J., MacPherson, K. P., DeBrouse, L., Colacicco, G., Flynn, S. M., Masneuf, S., Pleil, K. E., Li, C., Marcinkiewcz, C. A., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3204 · Cited by 218
Genetic and Environmental Predictors of Early Alcohol Use
Kaufman, J., Yang, B.-Z., Douglas-Palumberi, H., Crouse-Artus, M., Lipschitz, D., Krystal, J. H., & Gelernter, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.039 · Cited by 216
Robinson, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.75 · Cited by 208 · cited 18×
“Taken together, these findings point to noradrenergic dysregulation as a potential common mechanism driving the development and maintenance of stress-related anxiety, PTSD, and alcohol use disorder.”
BackgroundInfluentialSmith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206 · cited 5×
“Similarly, prazosin may be exerting its effects in part via antagonism of a1-AR in the bed nucleus of the stria terminalis (BNST), a nucleus of the extended amygdala thought to contribute to withdrawalrelated anxiety (Aston-Jones and Harris, 2004; Delfs et al., 2000; Walker et al., 2008).”
BackgroundInfluentialMaternal separation stress in male mice: long-term increases in alcohol intake
Cruz, F. C., Quadros, I. M., da S. Planeta, C., & Miczek, K. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1307-4 · Cited by 109
Hall, F. S., Huang, S., Pert, A., Linnoila, M., & Fong, G. W. (1998) · Psychopharmacology · doi:10.1007/s002130050706 · Cited by 104
Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats
Gilpin, N. W., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1967-8 · Cited by 99 · cited 2×
“, 1977), and decrease operant responding for ethanol in a rodent model of dependence (Gilpin and Koob, 2010).”
BackgroundPsychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
Yamamoto, K., Shinba, T., & Yoshii, M. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12126 · Cited by 88 · cited 2×
“In fact, hyperactivity of the noradrenergic system has been observed among individuals with anxiety disorders (Ressler and Nemeroff, 2001; Yamamoto et al., 2014), and cyclic alcohol intake and withdrawal likewise lead to increased central noradrenergic signaling (Lanteri et al., 2008; Patkar et…”
BackgroundBondi, C. O., Barrera, G., Lapiz, M. D. S., Bedard, T., Mahan, A., & Morilak, D. A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.11.015 · Cited by 56 · cited 1×
“Additionally, blockade of a1- or b1/2-ARs in the lateral septum, which is reciprocally connected to the amygdala, has been shown to reduce stress-related behaviors acutely (Bondi et al., 2007).”
Background
Cited by
Maren, S., & Holmes, A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.180 · Cited by 412
Rivera-Irizarry, J. K., Skelly, M. J., & Pleil, K. E. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00129 · Cited by 72
Self-citationSanchez-Marin, L., Pavon, F. J., Decara, J., Suarez, J., Gavito, A., Castilla-Ortega, E., Rodriguez de Fonseca, F., & Serrano, A. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00015 · Cited by 55
Reichelt, A. C., Loughman, A., Bernard, A., Raipuria, M., Abbott, K. N., Dachtler, J., Van, T. T. H., & Moore, R. J. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1537169 · Cited by 49
Adolescence alcohol exposure impairs fear extinction and alters medial prefrontal cortex plasticity
Lawson, K., Scarlata, M. J., Cho, W. C., Mangan, C., Petersen, D., Thompson, H. M., Ehnstrom, S., Mousley, A. L., Bezek, J. L., & Bergstrom, H. C. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109048 · Cited by 16
Metadata
- Authors
- Skelly, M. J., Chappell, A. E., Carter, E., & Weiner, J. L.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 97
- Pages
- 149-159
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W580921785
- Cited by
- 161
- References
- 25
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.